Episode
Transcelerate's Sponsor Considerations for Obtaining Site Feedback
- Published
- Oct 6, 2025
- Duration seconds
- 3404
- Processing state
not_requested- Canonical source
- https://www.dtra.org
Actions
POST https://stenobird.com/v1/public/podcasts/decentralized-the-decentralized-trials-research-podcast-6281264/episodes/transcelerate-s-sponsor-considerations-for-obtaining-site-feedback/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/decentralized-the-decentralized-trials-research-podcast-6281264/transcelerate-s-sponsor-considerations-for-obtaining-site-feedback.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
2025-10-03 Hosts Amir Kalali, Craig Lipset, and Jane Myles were joined by representatives from TransCelerate BioPharma Inc. ’s Modernizing Clinical Trial Conduct initiative for our discussion. This initiative is helping the industry move beyond pandemic-era adaptations toward lasting transformation. In this session, we highlighted a newly released tool designed to help sponsors collect meaningful site feedback to improve decentralized clinical trial (DCT) implementation. We discussed the importance of patient, site, and sponsor feedback in shaping trial design, and touch on other relevant resources that support more patient-centric, flexible, and resilient approaches. Hear from Laura Renton ( GSK ) and Anna Christiansson ( AstraZeneca ) in this practical discussion on these resources and how you can begin to apply them in your organization. Modernizing Clinical Trial Conduct Solutions Toolkit You can join TGIF-DTRA Sessions live on LinkedIn Live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X . Learn more about Membership options and our work at www.dtra.org .